Navigation Links
Americas Third Coast nurtures biotechnology

rials and in configurations capable of supplying ranges of motion across a full spectrum of requirements, explains a company spokesperson.

Milwaukee, Too

Based in Brown Deer, a Milwaukee suburb, Pel-Freez Clinical Systems (www.pel-freez.com) designs and manufactures serological and molecular biology products tha......

Full article >>>
'"/>

Source:wistechnology.com By Carol Potera 03/08/04


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Corporate Americas hidden deficit
2. Americas weighty problem: Why the fight against fat is about more than just looking good
3. Third Wave files countersuit vs. Digene in patent case
4. Third Wave reports net loss of $18.9M for 2006
5. Stratagene to pay Third Wave $10.75M in patent case
6. Third Wave responds to Digene patent lawsuit
7. Third Wave seeks approval of Cystic Fibrosis test
8. Third Wave Technologies to raise $14.9M through private debt
9. Third Wave reports $5.2M third quarter loss
10. Third Wave reports another loss, stronger sales
11. Napier joins board of Third Wave Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Americas Third Coast nurtures biotechnology

(Date:11/26/2014)... 2014 Silicon Valley Electronic Data Capture ... RPM Alliance , provider of clinical research and data ... latest addition to its CRO Partnership Program, Clinovo expands ... to India. , “We have found Clinovo’s ClinCapture ... EDC platform which is both user friendly and easy ...
(Date:11/26/2014)... 26, 2014 SoundConnect , an ... proud to announce that Darren Suders has joined the ... Darren will drive the partner program through ... , Darren brings more than 10-years of ... roles in channel operations, from policy development, to partner ...
(Date:11/26/2014)... , 25 novembre 2014 /PRNewswrie/ -- Theravalues Corporation ... il mercato europeo in occasione di Hi Europe 2014 ... ). Si tratta della curcumina con la ... amorfa (senza cristalli) e ingredienti approvati dalle norme europee. ... nella spezia della pianta curcumina ( Curcuma longa ) ...
(Date:11/24/2014)... Belgium , Nov. 24, 2014 ... focused on developing diagnostic tests for cancer and other conditions, ... will be presented at the Science for Business BioWin Day ... Belgium . The data come from VolitionRx,s lung cancer ... Pneumology department of the Centre Hospitalier Universitaire (CHU) de Liege ...
Breaking Biology Technology:RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2SoundConnect Appoints Director of Channel Development & Sales 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6
... 13, 2011 Tengion, Inc. (NASDAQ: TNGN ... new data from the Company,s Neo-Urinary Conduit™ (NUC) and ... at the TERMIS North America Annual Conference being held ... NUC program is further supported by various cellular and ...
... Dec. 13, 2011  Astellas Pharma Inc. (Tokyo: 4503, Astellas) ... from an interim analysis of a Phase 2 study ... were presented at the 53rd Annual Meeting of the ... Data were also presented from two additional posters: one ...
... PHILADELPHIA, Dec. 13, 2011 Tarsa Therapeutics today confirmed ... Application (NDA) to the Food and Drug Administration (FDA) ... company,s oral recombinant salmon calcitonin tablet for the treatment ... the FDA that verified the results from Tarsa,s Phase ...
Cached Biology Technology:Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 2Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 3Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 2Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 3Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 5Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 6Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 7Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 8Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 2Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 3
(Date:11/4/2014)... only marketing directed at children on the interior ... that the majority of black, middle-income and rural ... , Authored by Arizona State University researcher Punam ... first to examine the use of child-directed marketing ... restaurants and its relationship to demographics. It adds ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
(Date:11/2/2014)... of Physics World , James Dacey explores the ... death" to take their innovations from the lab into ... challenge facing all start-up companies as they move from ... of two main factors: physics-based inventions are usually far ... out to be a lot more complicated than had ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
... human survival and food security, especially as population density ... social insects to cultivate crops, have harvested plant material ... years. New results from the Smithsonian show that both ... coming into the nest inside leaves, thus ensuring the ...
... year, hundreds of thousands of people suffer medical complications ... skin. A new device developed by MIT engineers and ... needles on target. The device, which is purely ... industry. It involves a hollow S-shaped needle containing a ...
... has joined with a team of colleagues to propose ... research field that investigates heritable alterations in gene expression ... Dr. Shilatifard,s publication appeared today in ... meeting on December 7-10, 2008 that he co-organized at ...
Cached Biology News:Food security for leaf-cutting ants: Workers and their fungus garden reject endophyte invaders 2MIT: Novel needle could cut medical complications 2Ali Shilatifard and colleagues aim to clarify the definition of 'epigenetics' 2
... whose sequence is from the C-terminal end of the mouse retinoic acid ... acids 429 to 448 of RAR*. The sequence of PEP-005 is ... S - P - S - S - V - E - ... S - P - L - L - Q (The N-terminal ...
... Kit with Medium High quality ready-to-use cryopreserved ... base medium for growth and lineage commitment. ... generated from E18 fetal rat brain in ... mixture of in vitro stem/progenitor cells, neurons, ...
... for the use of small interfering RNA ... the RNA interference (RNAi) pathway have generated ... biology fields. siRNA for experimental use can ... enzymatically, and then transfected into the target ...
... for the use of small interfering RNA ... the RNA interference,(RNAi) pathway have generated tremendous ... fields. siRNA for experimental use can be,synthesized ... then transfected into the target cells in ...
Biology Products: